However, as you may have read, its rising popularity is not solely due to its efficacy in managing diabetes
Chronic, low-grade inflammation is a major feature of diabetes and its complications, particularly cardiovascular disease
In its Complete Response Letter, the FDA stated that the application did not provide substantial evidence of effectiveness to support its approval and that further research would be required
As diabetes management around the world is quickly evolving from algorithms to customized therapies, it makes sense to apply this strategy in the GCC region, given the increasing number of glucose-lowering drugs/therapies available on the market and noting that the individual circumstances of the patient undoubtedly affect their outcome [8]
Genetically engineered bacteria have been developed as diagnostic and therapeutic tools for the treatment of many diseases, including cancer (41), diabetes (38), inflammatory bowel disease (42, 43) and viral infection (44)
But the problem is made worse in the case of Not Today, Grey